Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5088469018 | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate Ag conjugated to Clostridium tetani toxoid protein | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 5088470017 | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid protein | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 5088471018 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (substance) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5088472013 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid protein | est un(e) (attribut) | Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated (substance) | true | Inferred relationship | Some | ||
| Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid protein | est un(e) (attribut) | Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated (substance) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| DCaT-VPI-Hib PENTACEL SP | a pour principe actif (attribut) | True | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid protein | Inferred relationship | Some | 6 |
| Act-HIB 10 micrograms per 0.5 milliliter powder and diluent for solution for injection Sanofi Pasteur Limited (real clinical drug) | a pour principe actif (attribut) | True | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid protein | Inferred relationship | Some | 1 |
| MENHIBRIX solution for injection GlaxoSmithKline Biologicals (real clinical drug) | a pour principe actif (attribut) | True | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid protein | Inferred relationship | Some | 1 |
| DPT-HB-Hib PENTAVAC PFS SII | a pour principe actif (attribut) | True | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid protein | Inferred relationship | Some | 3 |
| Hiberix 10 micrograms per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | True | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid protein | Inferred relationship | Some | 1 |
| DTaP-Hib ACTacel SP | a pour principe actif (attribut) | True | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid protein | Inferred relationship | Some | 2 |
| PEDIACEL suspension for injection Sanofi Pasteur Limited (real clinical drug) | a pour principe actif (attribut) | True | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid protein | Inferred relationship | Some | 6 |
| INFANRIX-IPV/Hib suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | True | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid protein | Inferred relationship | Some | 6 |
| INFANRIX hexa suspension for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | True | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid protein | Inferred relationship | Some | 5 |
| Vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (medicinal product) | a pour principe actif (attribut) | True | Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid protein | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR